These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9113050)

  • 1. [Asthma and Chlamydia pneumoniae. A future prospect for macrolides in general and roxithromycin in particular?].
    Mayaud C
    Presse Med; 1997 Mar; 26 Suppl 2():27-9. PubMed ID: 9113050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
    Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
    Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide and occult infection in asthma.
    Cazzola M; Matera MG; Blasi F
    Curr Opin Pulm Med; 2004 Jan; 10(1):7-14. PubMed ID: 14749600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for the treatment of asthma.
    Black PN
    Curr Opin Pharmacol; 2007 Jun; 7(3):266-71. PubMed ID: 17433889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can or should acute asthma exacerbations be treated with macrolides?].
    Peña M; Rubio M
    Rev Esp Quimioter; 1999 Jun; 12(2):99-103. PubMed ID: 10562668
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on infection and antibiotics in asthma.
    Rollins DR; Beuther DA; Martin RJ
    Curr Allergy Asthma Rep; 2010 Jan; 10(1):67-73. PubMed ID: 20425516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chlamydia pneumoniae: association with asthma and cardiovascular disease. Therapeutic interventions].
    Barbal JG
    Rev Esp Quimioter; 1998 Mar; 11(1):23-8. PubMed ID: 9795285
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.
    Melissano G; Blasi F; Esposito G; Tarsia P; Dordoni L; Arosio C; Tshomba Y; Fagetti L; Allegra L; Chiesa R
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):355-9. PubMed ID: 10550273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma in children: are chlamydia or mycoplasma involved?
    Esposito S; Principi N
    Paediatr Drugs; 2001; 3(3):159-68. PubMed ID: 11310715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma.
    Hahn DL; Bukstein D; Luskin A; Zeitz H
    Ann Allergy Asthma Immunol; 1998 Jan; 80(1):45-9. PubMed ID: 9475566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 17. [Asthma and infection: etiopathogenic factors and treatment with roxithromycin].
    Calvo PR; Pérez LA
    Rev Esp Quimioter; 1999 Mar; 12(1):69-73. PubMed ID: 10209064
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae, clarithromycin, and severe asthma.
    Kroegel C; Rödel J; Mock B
    Chest; 2001 Sep; 120(3):1035-6. PubMed ID: 11555549
    [No Abstract]   [Full Text] [Related]  

  • 20. Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.
    Webley WC; Hahn DL
    Respir Res; 2017 May; 18(1):98. PubMed ID: 28526018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.